论文部分内容阅读
目的分析氨氯地平阿托伐他汀钙片用于高血压合并冠心病的治疗效果。方法 130例高血压合并冠心病患者,随机分为对照组和观察组,各65例。对照组口服硝苯地平缓释片,观察组口服氨氯地平阿托伐他汀钙片,对比两组治疗效果及患者血压、血脂水平变化。结果观察组总有效率为95.38%,明显高于对照组的73.85%,差异具有统计学意义(P<0.05)。治疗后两组患者收缩压(SBP)、舒张压(DBP)、总胆固醇(TC)、甘油三酯(TG)均较治疗前明显改善,且观察组改善程度明显大于对照组(P<0.05)。结论氨氯地平阿托伐他汀钙片治疗高血压合并冠心病可取得满意疗效,值得推广应用。
Objective To analyze the therapeutic effect of amlodipine atorvastatin calcium tablets on hypertension with coronary heart disease. Methods A total of 130 hypertensive patients with coronary heart disease were randomly divided into control group and observation group, with 65 cases in each group. The control group was given oral nifedipine sustained-release tablets, and the observation group was given amlodipine atorvastatin calcium tablets. The therapeutic effect and the changes of blood pressure and blood lipid level were compared among the two groups. Results The total effective rate in the observation group was 95.38%, which was significantly higher than that in the control group (73.85%), the difference was statistically significant (P <0.05). After treatment, systolic blood pressure (SBP), diastolic blood pressure (DBP), total cholesterol (TC) and triglyceride (TG) in both groups were significantly improved than those before treatment, and the improvement in the observation group was significantly greater than that in the control group (P <0.05) . Conclusion Amlodipine atorvastatin calcium tablets can be used to treat hypertensive patients with coronary heart disease.